{
  "title": "Financial Statements - TechManufacture Inc.",
  "document_id": "ENT-2025-002",
  "version": "1.0",
  "last_updated": "2025-08-20",
  "content": "\n# FINANCIAL STATEMENTS: TECHMANUFACTURE INC.\n\n## INCOME STATEMENT (in thousands)\n\n| Line Item | FY 2022 | FY 2023 | FY 2024 | TTM 2025 |\n|----------|---------|---------|---------|----------|\n| **Revenue** | $32,450 | $37,318 | $42,915 | $46,750 |\n| Cost of Goods Sold | $18,857 | $21,445 | $24,462 | $26,196 |\n| **Gross Profit** | $13,593 | $15,873 | $18,453 | $20,554 |\n| Gross Margin | 41.9% | 42.5% | 43.0% | 44.0% |\n| Research & Development | $3,894 | $4,478 | $5,150 | $5,610 |\n| Sales & Marketing | $3,245 | $3,732 | $4,292 | $4,675 |\n| General & Administrative | $2,596 | $2,985 | $3,433 | $3,740 |\n| **Total Operating Expenses** | $9,735 | $11,195 | $12,875 | $14,025 |\n| **Operating Income** | $3,858 | $4,678 | $5,578 | $6,529 |\n| Operating Margin | 11.9% | 12.5% | 13.0% | 14.0% |\n| Interest Expense | $1,136 | $1,306 | $1,502 | $1,636 |\n| Other Income/(Expense) | $162 | $187 | $215 | $234 |\n| **Income Before Taxes** | $2,884 | $3,559 | $4,291 | $5,127 |\n| Income Tax Expense | $606 | $747 | $901 | $1,077 |\n| Effective Tax Rate | 21.0% | 21.0% | 21.0% | 21.0% |\n| **Net Income** | $2,278 | $2,812 | $3,390 | $4,050 |\n| Net Margin | 7.0% | 7.5% | 7.9% | 8.7% |\n| **EBITDA** | $5,834 | $6,901 | $8,154 | $9,350 |\n| EBITDA Margin | 18.0% | 18.5% | 19.0% | 20.0% |\n| **Adjusted EBITDA** | $6,166 | $7,277 | $8,583 | $9,817 |\n| Adjusted EBITDA Margin | 19.0% | 19.5% | 20.0% | 21.0% |\n\n## BALANCE SHEET (in thousands)\n\n| Line Item | FY 2022 | FY 2023 | FY 2024 | Current |\n|----------|---------|---------|---------|---------|\n| **ASSETS** |  |  |  |  |\n| Cash & Equivalents | $4,218 | $5,598 | $6,866 | $7,480 |\n| Accounts Receivable | $5,840 | $6,717 | $7,725 | $8,415 |\n| Inventory | $6,490 | $7,464 | $8,583 | $9,350 |\n| Other Current Assets | $973 | $1,120 | $1,287 | $1,403 |\n| **Total Current Assets** | $17,521 | $20,899 | $24,461 | $26,648 |\n| Property, Plant & Equipment | $18,500 | $21,275 | $24,466 | $26,650 |\n| Accumulated Depreciation | $(5,550) | $(7,446) | $(9,787) | $(11,307) |\n| **Net PP&E** | $12,950 | $13,829 | $14,679 | $15,343 |\n| Intangible Assets | $3,245 | $2,985 | $2,746 | $2,571 |\n| Goodwill | $4,500 | $4,500 | $4,500 | $4,500 |\n| Other Long-Term Assets | $1,298 | $1,493 | $1,717 | $1,870 |\n| **Total Assets** | $39,514 | $43,706 | $48,103 | $50,932 |\n| **LIABILITIES & EQUITY** |  |  |  |  |\n| Accounts Payable | $3,245 | $3,732 | $4,292 | $4,675 |\n| Accrued Expenses | $2,596 | $2,985 | $3,433 | $3,740 |\n| Current Portion of Debt | $1,623 | $1,866 | $2,146 | $2,338 |\n| Other Current Liabilities | $649 | $746 | $858 | $935 |\n| **Total Current Liabilities** | $8,113 | $9,329 | $10,729 | $11,688 |\n| Long-Term Debt | $14,603 | $15,793 | $17,166 | $17,038 |\n| Deferred Tax Liabilities | $1,298 | $1,493 | $1,717 | $1,870 |\n| Other Long-Term Liabilities | $973 | $1,120 | $1,287 | $1,403 |\n| **Total Liabilities** | $24,987 | $27,735 | $30,899 | $31,999 |\n| Common Stock | $100 | $100 | $100 | $100 |\n| Additional Paid-In Capital | $8,000 | $8,000 | $8,000 | $8,000 |\n| Retained Earnings | $6,427 | $7,871 | $9,104 | $10,833 |\n| **Total Equity** | $14,527 | $15,971 | $17,204 | $18,933 |\n| **Total Liabilities & Equity** | $39,514 | $43,706 | $48,103 | $50,932 |\n\n## CASH FLOW STATEMENT (in thousands)\n\n| Line Item | FY 2022 | FY 2023 | FY 2024 | TTM 2025 |\n|----------|---------|---------|---------|----------|\n| **OPERATING ACTIVITIES** |  |  |  |  |\n| Net Income | $2,278 | $2,812 | $3,390 | $4,050 |\n| Depreciation & Amortization | $1,976 | $2,223 | $2,576 | $2,821 |\n| Stock-Based Compensation | $325 | $373 | $429 | $468 |\n| Deferred Income Taxes | $162 | $195 | $224 | $153 |\n| Changes in Working Capital | $(811) | $(933) | $(1,073) | $(1,169) |\n| **Net Cash from Operations** | $3,930 | $4,670 | $5,546 | $6,323 |\n| **INVESTING ACTIVITIES** |  |  |  |  |\n| Capital Expenditures | $(2,921) | $(3,359) | $(3,862) | $(4,208) |\n| Acquisitions | $0 | $0 | $(1,500) | $0 |\n| Other Investing Activities | $(162) | $(187) | $(215) | $(234) |\n| **Net Cash from Investing** | $(3,083) | $(3,546) | $(5,577) | $(4,442) |\n| **FINANCING ACTIVITIES** |  |  |  |  |\n| Net Change in Debt | $1,298 | $1,433 | $1,653 | $64 |\n| Dividends Paid | $(649) | $(746) | $(858) | $(935) |\n| Share Repurchases | $(325) | $(373) | $(429) | $(468) |\n| Other Financing Activities | $(162) | $(58) | $(67) | $72 |\n| **Net Cash from Financing** | $162 | $256 | $299 | $(1,267) |\n| **Net Change in Cash** | $1,009 | $1,380 | $268 | $614 |\n| **Beginning Cash Balance** | $3,209 | $4,218 | $5,598 | $6,866 |\n| **Ending Cash Balance** | $4,218 | $5,598 | $6,866 | $7,480 |\n\n## FINANCIAL RATIOS\n\n| Ratio | FY 2022 | FY 2023 | FY 2024 | Current | Industry Median |\n|-------|---------|---------|---------|---------|----------------|\n| **LIQUIDITY RATIOS** |  |  |  |  |  |\n| Current Ratio | 2.16x | 2.24x | 2.28x | 2.28x | 1.95x |\n| Quick Ratio | 1.36x | 1.44x | 1.48x | 1.48x | 1.25x |\n| Cash Ratio | 0.52x | 0.60x | 0.64x | 0.64x | 0.45x |\n| **LEVERAGE RATIOS** |  |  |  |  |  |\n| Debt/EBITDA | 2.79x | 2.56x | 2.37x | 2.07x | 2.50x |\n| Debt/Tangible Net Worth | 1.13x | 1.09x | 1.05x | 0.98x | 1.20x |\n| Interest Coverage | 3.40x | 3.58x | 3.71x | 3.99x | 3.20x |\n| Fixed Charge Coverage | 2.85x | 3.00x | 3.15x | 3.40x | 2.75x |\n| **PROFITABILITY RATIOS** |  |  |  |  |  |\n| Gross Margin | 41.9% | 42.5% | 43.0% | 44.0% | 40.0% |\n| EBITDA Margin | 18.0% | 18.5% | 19.0% | 20.0% | 17.5% |\n| Return on Assets | 5.8% | 6.4% | 7.0% | 8.0% | 5.5% |\n| Return on Equity | 15.7% | 17.6% | 19.7% | 21.4% | 16.0% |\n| **EFFICIENCY RATIOS** |  |  |  |  |  |\n| Inventory Turnover | 2.91x | 3.07x | 3.05x | 3.00x | 3.25x |\n| Days Inventory Outstanding | 125.6 | 118.9 | 119.7 | 121.7 | 112.3 |\n| Receivables Turnover | 5.56x | 5.94x | 5.95x | 5.95x | 6.20x |\n| Days Sales Outstanding | 65.7 | 61.4 | 61.3 | 61.3 | 58.9 |\n| Asset Turnover | 0.82x | 0.85x | 0.89x | 0.92x | 0.85x |\n| **GROWTH RATES** |  |  |  |  |  |\n| Revenue Growth | 12.5% | 15.0% | 15.0% | 8.9% | 10.0% |\n| EBITDA Growth | 15.0% | 18.3% | 18.2% | 14.7% | 12.0% |\n| Net Income Growth | 18.0% | 23.4% | 20.6% | 19.5% | 14.0% |\n\n## COVENANT COMPLIANCE\n\n| Covenant | Requirement | FY 2022 | FY 2023 | FY 2024 | Current | Status |\n|----------|------------|---------|---------|---------|---------|--------|\n| Leverage Ratio | \u2264 3.00x | 2.79x | 2.56x | 2.37x | 2.07x | Compliant |\n| Fixed Charge Coverage | \u2265 1.50x | 2.85x | 3.00x | 3.15x | 3.40x | Compliant |\n| Current Ratio | \u2265 1.50x | 2.16x | 2.24x | 2.28x | 2.28x | Compliant |\n| Tangible Net Worth | \u2265 $12MM | $14.5MM | $16.0MM | $17.2MM | $18.9MM | Compliant |\n\n## DEBT SCHEDULE\n\n| Facility | Original Amount | Current Balance | Interest Rate | Maturity | Monthly Payment | Collateral |\n|----------|----------------|----------------|--------------|----------|----------------|-----------|\n| Revolving Line of Credit | $10,000,000 | $6,500,000 | SOFR + 2.25% | 12/31/2025 | Interest Only | A/R, Inventory |\n| Commercial Real Estate Loan | $10,000,000 | $8,300,000 | 4.75% Fixed | 06/30/2035 | $52,150 | Real Estate |\n| Equipment Term Loan | $6,000,000 | $4,500,000 | SOFR + 2.50% | 03/31/2028 | $113,250 | Equipment |\n| Letter of Credit Facility | $2,500,000 | $876,000 | 1.50% | 12/31/2025 | Fee Based | Cash Secured |\n\n## PROJECTIONS (in thousands)\n\n| Line Item | FY 2025 | FY 2026 | FY 2027 |\n|----------|---------|---------|---------|\n| **Revenue** | $49,350 | $56,750 | $65,260 |\n| YoY Growth | 15.0% | 15.0% | 15.0% |\n| Gross Profit | $21,714 | $25,538 | $30,020 |\n| Gross Margin | 44.0% | 45.0% | 46.0% |\n| EBITDA | $9,870 | $11,918 | $14,357 |\n| EBITDA Margin | 20.0% | 21.0% | 22.0% |\n| Net Income | $4,442 | $5,675 | $7,179 |\n| Net Margin | 9.0% | 10.0% | 11.0% |\n| Capital Expenditures | $4,442 | $5,108 | $5,873 |\n| % of Revenue | 9.0% | 9.0% | 9.0% |\n| Free Cash Flow | $3,948 | $5,107 | $6,484 |\n| Total Debt | $19,740 | $18,753 | $17,815 |\n| Debt/EBITDA | 2.00x | 1.57x | 1.24x |\n\n## CAPITAL EXPENDITURE PLAN\n\n| Project | Amount | Timing | Description | Expected Return |\n|---------|--------|--------|-------------|----------------|\n| SMT Line Upgrade | $2,500,000 | Q4 2025 - Q1 2026 | New high-speed, high-precision surface mount technology line | 22% IRR, 3.5 year payback |\n| Clean Room Expansion | $1,800,000 | Q2-Q3 2026 | Expansion of Class 10,000 clean room for medical device manufacturing | 18% IRR, 4.2 year payback |\n| Test Equipment | $1,200,000 | Q3-Q4 2025 | Advanced environmental and reliability testing equipment | 25% IRR, 3.0 year payback |\n| Facility Improvements | $850,000 | Throughout 2025-2026 | Energy efficiency upgrades, HVAC improvements, security enhancements | 15% IRR, 5.0 year payback |\n| R&D Lab Equipment | $750,000 | Q1-Q2 2026 | New prototyping and testing equipment for R&D facility | 20% IRR, 3.8 year payback |\n\n## NOTES TO FINANCIAL STATEMENTS\n\n1. **Revenue Recognition:** Revenue is recognized when products are shipped to customers or when services are performed. The company has adopted ASC 606 for revenue recognition.\n\n2. **Inventory Valuation:** Inventories are stated at the lower of cost or net realizable value, with cost determined on a first-in, first-out (FIFO) basis.\n\n3. **Depreciation:** Property, plant, and equipment are depreciated using the straight-line method over estimated useful lives ranging from 3 to 30 years.\n\n4. **Intangible Assets:** Intangible assets consist primarily of patents, developed technology, and customer relationships acquired through acquisitions, amortized over 5-15 years.\n\n5. **R&D Expenses:** Research and development costs are expensed as incurred, except for certain software development costs that qualify for capitalization.\n\n6. **Adjusted EBITDA:** Excludes stock-based compensation, acquisition-related expenses, and non-recurring legal settlements.\n\n7. **Segment Reporting:** The company operates as a single reportable segment based on how the business is managed and evaluated.\n\n8. **Foreign Currency:** Approximately 35% of revenue is derived from international customers, primarily in Europe and Asia. The company uses forward contracts to hedge certain foreign currency exposures.\n\n9. **Subsequent Events:** In August 2025, the company signed a new 5-year supply agreement with its largest customer, representing approximately 12% of annual revenue.\n    "
}